Company Viracta Therapeutics, Inc. Nasdaq
Equities
US92765F1084
Biotechnology & Medical Research
Business Summary
Number of employees: 40
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Rothera
CEO | Chief Executive Officer | 62 | 19/22/19 |
Melody Burcar
DFI | Director of Finance/CFO | 41 | 01/22/01 |
Chief Tech/Sci/R&D Officer | - | - | |
Darrel Cohen
CTO | Chief Tech/Sci/R&D Officer | 59 | 07/23/07 |
Ayman El-Guindy
CTO | Chief Tech/Sci/R&D Officer | - | 06/21/06 |
Ivor Royston
BRD | Director/Board Member | 79 | 01/07/01 |
Ashleigh Barreto
IRC | Investor Relations Contact | - | 01/21/01 |
Corporate Officer/Principal | - | 06/21/06 | |
Patric Nelson
PRN | Corporate Officer/Principal | - | 06/21/06 |
Cheryl A. Madsen
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ivor Royston
BRD | Director/Board Member | 79 | 01/07/01 |
Thomas Darcy
BRD | Director/Board Member | 74 | 01/21/01 |
Barry Simon
BRD | Director/Board Member | 69 | 03/21/03 |
Mark Rothera
CEO | Chief Executive Officer | 62 | 19/22/19 |
Roger Pomerantz
CHM | Chairman | 67 | 01/20/01 |
Flavia Borellini
BRD | Director/Board Member | 65 | 14/21/14 |
Jane Barlow
BRD | Director/Board Member | 63 | 14/21/14 |
Stephen Rubino
BRD | Director/Board Member | 65 | 03/21/03 |
Sam Murphy
BRD | Director/Board Member | - | 01/19/01 |
Jane Chung
BRD | Director/Board Member | 53 | 10/22/10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 39,272,434 | 38,184,370 ( 97.23 %) | 0 | 97.20 % |
Stock B | 0 | 10,248 | 0 | 0 |
Company contact information
Viracta Therapeutics, Inc.
2533 South Coast Highway 101 Suite 210
92007, Cardiff
+
http://www.viracta.comSector
1st Jan change | Capi. | |
---|---|---|
+19.54% | 46.81B | |
-0.71% | 41.37B | |
+47.07% | 41.29B | |
-6.20% | 28.87B | |
+11.79% | 26.06B | |
-19.66% | 19.13B | |
+32.80% | 12.39B | |
+0.33% | 12.08B | |
+0.30% | 11.96B |